• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013-2017 年葡萄牙潜伏性结核感染治疗失败:与地理、社会人口学和医疗相关的因素。

Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.

机构信息

Directorate-General of Health, Lisbon, Portugal.

European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden.

出版信息

Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):647-656. doi: 10.1007/s10096-019-03765-y. Epub 2019 Dec 3.

DOI:10.1007/s10096-019-03765-y
PMID:31797155
Abstract

There is conflicting evidence about factors associated with failure to complete treatment (FCT) for latent tuberculosis infection (LTBI). We aim to identify the geographic, sociodemographic, and medical factors associated with FCT in Portugal, highlighting the two main metropolitan areas of Porto and Lisbon. We performed a retrospective cohort study including LTBI patients that started treatment in Portugal between 2013 and 2017. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) using multivariable logistic regression to identify geographic, sociodemographic, and medical factors associated with FCT. Data on completion of treatment were available for 15,478 of 17,144 patients (90.3%). Of those, 2132 (13.8%) failed to complete treatment. Factors associated with FCT were being older than 15 years (aOR, 1.65 (95% CI = 1.34-2.05) for those aged 16 to 29), being born abroad (aOR, 2.04 (95% CI = 1.19-3.50) for Asia; aOR, 1.57 (95% CI = 1.24-1.98) for Africa), having a chronic disease (aOR, 1.29 (95% CI = 1.04-1.60)), alcohol abuse (aOR, 2.24 (95% CI = 1.73-2.90)), and being intravenous drug user (aOR, 1.68 (95% CI = 1.05-2.68)). Three-month course treatment with isoniazid plus rifampicin was associated with decreased FCT when compared with 6- or 9-month courses of isoniazid-only (aOR, 0.59 (95% CI = 0.45-0.77)). In Lisbon metropolitan area, being born in Africa, and in Porto metropolitan area, alcohol abusing and being intravenous drug user were distinctive factors associated with FCT. Sociodemographic and medical factors associated with FCT may vary by geographical area and should be taken into account when planning interventions to improve LTBI treatment outcomes. This study reinforces that shorter course treatment for LTBI might reduce FCT.

摘要

关于潜伏性结核感染 (LTBI) 治疗失败 (FCT) 相关因素的证据相互矛盾。我们的目的是确定与葡萄牙 FCT 相关的地理、社会人口学和医学因素,重点关注波尔图和里斯本这两个主要的大都市区。我们进行了一项回顾性队列研究,纳入了 2013 年至 2017 年间在葡萄牙开始治疗的 LTBI 患者。我们使用多变量逻辑回归计算了调整后的优势比 (aOR) 和 95%置信区间 (95%CI),以确定与 FCT 相关的地理、社会人口学和医学因素。在 17144 名患者中,有 15478 名(90.3%)完成了治疗。其中,2132 名(13.8%)未完成治疗。与 FCT 相关的因素包括年龄超过 15 岁(aOR,16-29 岁者为 1.65 (95%CI = 1.34-2.05))、出生在国外(aOR,亚洲人为 2.04 (95%CI = 1.19-3.50);非洲人为 1.57 (95%CI = 1.24-1.98))、患有慢性病(aOR,1.29 (95%CI = 1.04-1.60))、酗酒(aOR,2.24 (95%CI = 1.73-2.90))和静脉吸毒者(aOR,1.68 (95%CI = 1.05-2.68))。与 6 个月或 9 个月异烟肼单药疗程相比,3 个月异烟肼加利福平疗程与 FCT 降低相关(aOR,0.59 (95%CI = 0.45-0.77))。在里斯本大都市区,出生在非洲,在波尔图大都市区,酗酒和静脉吸毒是与 FCT 相关的独特因素。与 FCT 相关的社会人口学和医学因素可能因地理区域而异,在规划改善 LTBI 治疗结果的干预措施时应予以考虑。本研究进一步证实,较短疗程治疗 LTBI 可能会降低 FCT。

相似文献

1
Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.2013-2017 年葡萄牙潜伏性结核感染治疗失败:与地理、社会人口学和医疗相关的因素。
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):647-656. doi: 10.1007/s10096-019-03765-y. Epub 2019 Dec 3.
2
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.挪威潜伏性结核感染的治疗完成情况:一项前瞻性队列研究。
BMC Infect Dis. 2018 Nov 19;18(1):587. doi: 10.1186/s12879-018-3468-z.
3
Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.日本潜伏性结核感染患者的趋势及治疗状况——基于日本结核病监测数据的分析
PLoS One. 2017 Nov 1;12(11):e0186588. doi: 10.1371/journal.pone.0186588. eCollection 2017.
4
Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.与潜伏性结核感染治疗随机试验中治疗依从性相关的因素。
Int J Tuberc Lung Dis. 2010 May;14(5):551-9.
5
Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.日本移民潜伏性结核感染的趋势和治疗结果:日本结核病监测数据的回顾性分析。
BMC Infect Dis. 2021 Jan 9;21(1):42. doi: 10.1186/s12879-020-05712-1.
6
Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.与商业健康保险患者潜伏性结核病感染治疗失败相关的因素-美国,2005-2016 年。
J Public Health Manag Pract. 2021;27(4):E151-E161. doi: 10.1097/PHH.0000000000001077.
7
Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.通过结核病诊所每月直接发放药物,完成潜伏性结核感染的治疗。
PLoS One. 2012;7(11):e48900. doi: 10.1371/journal.pone.0048900. Epub 2012 Nov 5.
8
Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.评估基层医疗医生在潜伏性结核病治疗中的作用:一项人群研究。
Int J Tuberc Lung Dis. 2014 Dec;18(12):1449-54. doi: 10.5588/ijtld.14.0166.
9
Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.在纽约市临床人群中治疗潜伏性结核感染的坚持情况。
Int J Infect Dis. 2010 Apr;14(4):e292-7. doi: 10.1016/j.ijid.2009.05.007. Epub 2009 Aug 4.
10
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.与潜伏性结核感染治疗未完成相关的因素:来自美国和加拿大预防结核病试验的经验。
Clin Infect Dis. 2016 Jun 1;62(11):1390-1400. doi: 10.1093/cid/ciw126. Epub 2016 Mar 6.

引用本文的文献

1
Impact of alcohol consumption, substance use, and smoking on treatment outcomes in tuberculosis: a systematic review and meta-analysis.饮酒、物质使用和吸烟对结核病治疗结果的影响:一项系统评价和荟萃分析。
Syst Rev. 2025 Jul 5;14(1):139. doi: 10.1186/s13643-025-02888-y.
2
Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial.与接受抗结核治疗的HIV感染者死亡率、严重发病率及治疗失败相关的结核病疾病特征——ANRS 12300 Reflate TB2试验的二次分析
BMC Infect Dis. 2025 May 14;25(1):695. doi: 10.1186/s12879-025-10986-4.
3

本文引用的文献

1
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.欧盟/欧洲经济区潜伏性结核感染的规划管理指南
Eur Respir J. 2019 Jan 17;53(1). doi: 10.1183/13993003.02077-2018. Print 2019 Jan.
2
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核:利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
3
Safety and Side Effects of Rifampin versus Isoniazid in Children.利福平与异烟肼在儿童中的安全性和副作用。
Knowledge and Attitudes About Screening and Preventive Treatment of Latent Tuberculosis Infection Among Patients with Rheumatic Diseases in Beijing, China.
中国北京风湿性疾病患者对潜伏性结核感染筛查及预防性治疗的认知与态度
Infect Drug Resist. 2024 Aug 7;17:3403-3414. doi: 10.2147/IDR.S471448. eCollection 2024.
4
Factors associated with incomplete tuberculosis preventive treatment: a retrospective analysis of six-years programmatic data in Cambodia.与结核病预防治疗不完整相关的因素:柬埔寨六年规划数据的回顾性分析。
Sci Rep. 2024 Aug 9;14(1):18458. doi: 10.1038/s41598-024-67845-6.
5
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review.异烟肼用于治疗潜伏性结核感染的使用、疗效和安全性:系统评价。
Rev Soc Bras Med Trop. 2024 Mar 25;57:e004022024. doi: 10.1590/0037-8682-0504-2023. eCollection 2024.
6
A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.儿科潜伏性结核感染护理环节的范围综述:初始步骤缺失。
BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2020-004836.
N Engl J Med. 2018 Aug 2;379(5):454-463. doi: 10.1056/NEJMoa1714284.
4
Comparative Study Between Tuberculosis Incidence Rates in the Two Largest Metropolitan Areas of Portugal.葡萄牙两个最大都市地区结核病发病率的比较研究。
Arch Bronconeumol (Engl Ed). 2018 Nov;54(11):595-596. doi: 10.1016/j.arbres.2018.05.003. Epub 2018 Jun 6.
5
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.自我给药与直接观察下的每周一次异烟肼和利福喷汀治疗潜伏性结核感染:一项随机试验。
Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7.
6
Preventive therapy for latent tuberculosis infection-the promise and the challenges.潜伏性结核感染的预防治疗——前景与挑战。
Int J Infect Dis. 2017 Mar;56:68-76. doi: 10.1016/j.ijid.2016.11.006. Epub 2016 Nov 18.
7
Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.改善潜伏性结核感染治疗依从性的干预措施:一项系统评价
BMC Infect Dis. 2016 Jun 8;16:257. doi: 10.1186/s12879-016-1549-4.
8
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.与潜伏性结核感染治疗未完成相关的因素:来自美国和加拿大预防结核病试验的经验。
Clin Infect Dis. 2016 Jun 1;62(11):1390-1400. doi: 10.1093/cid/ciw126. Epub 2016 Mar 6.
9
Social profile of the highest tuberculosis incidence areas in Portugal.葡萄牙结核病发病率最高地区的社会概况。
Rev Port Pneumol (2006). 2016 Jan-Feb;22(1):50-2. doi: 10.1016/j.rppnen.2015.08.006. Epub 2015 Oct 26.
10
Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.非透析的重症慢性肾脏病患者、接受透析治疗的患者及透析单位工作人员中潜伏性结核感染患病率的比较:一项横断面研究
PLoS One. 2015 Apr 28;10(4):e0124104. doi: 10.1371/journal.pone.0124104. eCollection 2015.